Neuropace, Inc. (NASDAQ: NPCE), a key player in the medical devices industry, is attracting significant attention from investors due to its innovative solutions in treating drug-resistant focal epilepsy. Founded in..
Capricor Therapeutics, Inc. (NASDAQ: CAPR) stands as a compelling player in the biotechnology sector, focusing on pioneering therapies for Duchenne muscular dystrophy (DMD) and other critical unmet medical needs. With..
Oruka Therapeutics, Inc. (ORKA) stands out in the biotechnology sector as a clinical-stage biopharmaceutical company making significant strides in developing innovative monoclonal antibody therapeutics. With a market capitalization of $1.37..
In the dynamic world of healthcare, Semler Scientific, Inc. (NASDAQ: SMLR) stands as a noteworthy player, offering innovative solutions to medical professionals across the United States. With its flagship product,..
For investors with a keen eye on the biotechnology sector, MeiraGTx Holdings plc (NASDAQ: MGTX) presents a compelling opportunity, boasting a potential upside of 227.84%. Specializing in gene therapy treatments,..
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) is a prominent name within the biotechnology industry, operating at the intersection of healthcare and technology with a focus on cell programming. Headquartered in..
AngioDynamics, Inc. (ANGO), a noteworthy entity in the healthcare sector, operates at the intersection of innovation and necessity within the medical instruments and supplies industry. Headquartered in Latham, New York,..
Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) stands out in the healthcare sector, particularly in the competitive biotechnology industry, with a notable potential upside that has caught the attention of investors...
Immunome, Inc. (NASDAQ: IMNM), a clinical-stage biotechnology firm, is gaining significant attention among investors, particularly due to its promising pipeline of targeted cancer therapies and a notable 54.84% potential upside..
Tilray Brands, Inc. (NASDAQ: TLRY) has positioned itself at the intersection of the burgeoning cannabis industry and lifestyle consumer products, with a diverse portfolio ranging from medical cannabis to beverage..
Oculis Holding AG (NASDAQ: OCS), a burgeoning name in the biotechnology industry, is captivating investor attention with its promising pipeline of ophthalmic treatments and a compelling potential upside of 117.85%...
Autolus Therapeutics plc (NASDAQ: AUTL) stands as a compelling figure in the biotechnology industry, particularly for those investors with a keen interest in the healthcare sector. Based in London, this..
Nuvation Bio Inc. (NASDAQ: NUVB) is drawing considerable attention from the investment community with its remarkable 72.64% potential upside, as indicated by analyst ratings. This clinical-stage biopharmaceutical company, headquartered in..
Bioventus Inc. (NASDAQ: BVS), a pivotal player in the healthcare sector, specializes in innovative medical devices aimed at alleviating pain and enhancing musculoskeletal therapies. With a market capitalization of $500.35..
Investors with an eye for innovative healthcare solutions should take a closer look at Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a pioneer in the biopharmaceutical industry focusing on brain health..
Personalis, Inc. (NASDAQ: PSNL) is carving a niche in the diagnostics and research sector with its cutting-edge genomic tests and services aimed at revolutionizing cancer detection and treatment. Despite facing..
Tectonic Therapeutic, Inc. (NASDAQ: TECX) is emerging as a compelling investment opportunity within the biotechnology sector, particularly for those with an appetite for high-growth potential. With a market capitalization of..
Zenas BioPharma, Inc. (NASDAQ: ZBIO) is capturing the attention of investors with its promising potential for growth in the biotechnology sector. With a market capitalization of $1.53 billion, this clinical-stage..
Talkspace, Inc. (NASDAQ: TALK) has been gaining traction in the healthcare sector, specifically within the burgeoning field of virtual behavioral health services. The company, which connects individuals with licensed mental..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) stands at the forefront of the biotechnology sector, captivating investor attention with its promising clinical-stage developments and a potential upside of 45.60% as indicated by..
